Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ef3ceb37d14fec74252b39bb03a0e9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a50eae0f3ecf0e195b803d595f1abad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8ebaa1065c4fb413aa993f6e8462680 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f48bbe869c4f355b831cfa81494860 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5a276193d9ed01ee4084b87d5cb8c68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86c58e3cc6b5366275f8f185e4ba446e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_603c016bb536ac9e102715440de8da66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e053f2e5e02ab835065a98f261f19583 |
publicationDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019170730-A1 |
titleOfInvention |
Ecm composition, tumor microenvironment platform and methods thereof |
abstract |
The present disclosure relates to an Extra Cellular Matrix composition specific for cancer type and a tumor microenvironment platform for long term culturing of tumor tissue, wherein said culturing provides human ligands and tumor tissue micro-environment to mimic physiologically relevant signalling systems. The present disclosure further relates to the development of a Clinical Response Predictor and its application in the prognostic field (selection of treatment option for the patient) and translational biology field (development of anticancer drugs). The disclosure further relates to a method of predicting clinical response of a tumor patient to drug(s). The disclosure further relates to a method for screening tumor cells for the presence of specific markers for determining the viability of said cells for indication of tumor status. |
priorityDate |
2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |